To access this element change to forms mode OFF
Grant Award View - GA268501
The Platform Trial in COVID-19 Boosting: stage 2 (PICOBOO-2)
GA ID:
GA268501
Agency:
Department of Health and Aged Care
Approval Date:
19-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
19-Jun-2022 to 31-May-2025
Value (AUD):
$3,830,631.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
The Platform Trial in COVID-19 Boosting: stage 2 (PICOBOO-2)
Purpose:
It is unclear whether periodic C-19 booster vaccination will be necessary in the future, and if so, whether this will be required for all Australians or select vulnerable groups. We will extend the Platform trial in COVID-19 vaccine BOOsting (PICOBOO) to evaluate optimal 3rd dose booster strategies in young children (5-11 years) and adolescents (12-17 years) and 4th dose booster strategies in pregnant women (18-49 years) and adults to inform national immunisation practice and policy.
GO ID:
GO Title:
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity
Internal Reference ID:
2022/MRF2016473
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Western Australia
Recipient ABN:
37 882 817 280
Grant Recipient Location
Suburb:
Nedlands
Town/City:
Nedlands
Postcode:
6009
State/Territory:
WA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA, WA, TAS
Postcode:
Multiple
Country:
AUSTRALIA